PUBLICATIONS OF BRIAN J MORRIS: 1972–2011
OVERVIEW
Total number = 302
Includes 266 published in international peer-reviewed journals + 18 chapters
• 156 on laboratory-based research findings in international journals, after
regular submission and review.
• 38 reviews solicited by, and published in, refereed international journals.
• 13 solicited as chapters in edited books.
• 49 more research papers and reviews in international journals (44) or
chapters in books (5) after submission at meetings (reviewed)
• 16 Letters to the Editor published in international journals
• 15 brief communications
• 14 in scholarly magazines.
• 1 invited book review in journal.
• 2 monographs (not included in numbering)
Contribution:
Wrote most and initiated work in most.
Publications are listed under the following subheadings:
• Refereed research papers in international journals
• Invited reviews in international journals
14
• Invited reviews as chapters in books
• Refereed journal articles and book chapters invited
for submission at conferences
• Letters to the Editor published in refereed journals
Brief communications
• Scholarly magazines
• Invited book review
• Monographs (not included in publication count above)
• Theses (not included in publication count above)
• Patent granted (not included in publication count above)
CITATION OF PUBLICATIONS
(Not all publications are listed on the pages that follow)
Page
2
17
18
23
24
25
26
26
27
28
29
B.J Morris – PUBLICATIONS
REFEREED RESEARCH PAPERS IN INTERNATIONAL
JOURNALS
1.*
Morris BJ, Lumbers ER. The activation of renin in human amniotic fluid by
proteolytic enzymes. Biochimica et Biophysica Acta 1972; 289: 385-391
3.
Morris BJ, Hutchinson JS, Johnston CI. Clearance and metabolism of
neurophysins by rat kidney. Journal of Endocrinology 1975; 64: 201-213
5.
Morris BJ, Cross SAM, Johnston CI. Clearance from the circulation of the rat
and whole-body autoradiography in the mouse of 125I-labelled neurophysins.
Clinical and Experimental Pharmacology & Physiology 1975; 2: 345-351
7.
Morris BJ, Nixon RL, Johnston CI. Release of renin from glomeruli isolated
from rat kidney. Clinical and Experimental Pharmacology & Physiology 1976;
3: 37-47
8.*
Morris BJ, Johnston CI. Renin substrate in granules from rat kidney cortex.
Biochemical Journal 1976; 154: 625-637
9.*
Morris BJ, Johnston CI. Isolation of renin granules from rat kidney cortex and
evidence for an inactive form of renin (prorenin) in granules and plasma.
Endocrinology 1976; 98: 1466-1474
10.
Morris BJ. Specific radioactivity of radioimmunoassay tracer determined by
self-displacement: a re-evaluation. Clinica Chimica Acta 1976; 73: 213-216
12.
Morris BJ. Mechanism of interference by chelating agents and sucrose in
radioimmunoassay of angiotensin I. Clinica Chimica Acta 1977; 75: 503-507
13.
Morris BJ, Davis JO, Zatzman ML, Williams GM. The renin-angiotensinaldosterone system in rabbits with congestive heart failure produced by aortic
constriction. Circulation Research 1977; 40: 275-282
14.
Morris BJ, Johnston CI. Identification of "angiotensin immunoreactive
material" in rat kidney. Endocrinology 1977; 100: 1409-1417
15.*
Morris BJ. Activation of human inactive ("pro-") renin by cathepsin D and
pepsin. Journal of Clinical Endocrinology and Metabolism 1978; 46: 153-157
17.
Morris BJ, Reid IA. The distribution of angiotensinogen in dog brain studied
by cell fractionation. Endocrinology 1978; 103: 492-500
20.
Morris BJ, Reid IA. A "renin-like" enzymatic action of cathepsin D and the
similarity in subcellular distributions of "renin-like" activity and cathepsin D in
the midbrain of dogs. Endocrinology 1978; 103: 1289-1296
21.
Morris BJ. Properties of the activation by pepsin of inactive renin in human
amniotic fluid. Biochimica et Biophysica Acta 1978; 527: 86-97
25.
Morris BJ, Moffat B, Reid IA. Partial purification of dog angiotensinogen.
American Journal of Physiology 1979; 236: E655-E659
2
B.J Morris – PUBLICATIONS
26.
Morris BJ, Iwamoto HS, Reid IA. Localization of angiotensinogen in rat liver
by immunocytochemistry. Endocrinology 1979; 105: 796-800
27.
Morris BJ, Reid IA, Ganong WF. Inhibition by -adrenoceptor agonists of
renin release in vitro. European Journal of Pharmacology 1979; 59: 37-45
28.
Day RP, Morris BJ. Properties of inactive renin in human plasma. Clinical
and Experimental Pharmacology & Physiology 1979; 6: 611-624
29.
Herrmann HC, Morris BJ, Reid IA. Effect of angiotensin II and sodium
depletion on angiotensinogen production. American Journal of Physiology
1980; 238: E145-E149
30.
Morris BJ, Lawrence CH. Activation of inactive renin during the selective
destruction of proteinase inhibitors in human plasma by a metalloproteinase
in Bitis arietans venom. Biochimica et Biophysica Acta 1980; 612: 137-142
37.
Morris BJ, de Zwart RT, Young JA. Renin in mouse but not in rat
submandibular glands. Experientia 1980; 36: 1333-1334
39.
Lawrence CH, Morris BJ. Mechanism of activation of inactive renin in human
plasma by puff adder venom. Biochimica et Biophysica Acta 1981; 657: 13-25
41.
Morris BJ, Catanzaro DF, de Zwart RT. Evidence that the arginine
esteropeptidase (gamma) subunit of nerve growth factor can activate inactive
renin. Neuroscience Letters 1981; 24: 87-92
44.
Morris BJ, McGirr JG. Direct evidence, using Pro-Phe-ArgCH2Cl, that
plasma kallikrein has a role in acid activation of inactive renin in plasma from
normal subjects. Biomedical Research 1981; 2: 552-559
46.
Morris BJ, Roper KJ. Investigation of the presence of "renopressin" in kidney
extracts from rabbits and rats. Hypertension 1982; 4: 198-204
47.*
Richards RI, Catanzaro DF, Mason AJ, Morris BJ, Baxter JD, Shine J.
Mouse glandular kallikrein genes. Nucleotide sequence of cloned cDNA
coding for a member of the kallikrein arginyl esteropeptidase group of serine
proteases. Journal of Biological Chemistry 1982; 257: 2758-2761
53.
Morris BJ, Cheng ESP. Clearance and metabolism of 125I-labeled tonin in
the rat. Endocrinology 1982; 111: 1462-1468
54.
Cheng ESP, Morris BJ. A simple method of isolating tonin using
chromatofocusing. Analytical Biochemistry 1982; 126: 295-300
55.
Robinson BG, Clifton-Bligh P, Posen S, Morris BJ. The effect of
bromocryptine on circulating vasopressin. Clinical Science 1982; 63: 367-372
56.
Robinson BG, Clifton-Bligh P, Posen S, Morris BJ. Plasma vasopressin in
hypercalcaemic states. Australian and New Zealand Journal of Medicine
1983; 13: 5-7
59.
Mesterovic N, Catanzaro DF, Morris BJ. Detection of renin mRNA in mouse
kidney and submandibular gland by hybridization with renin cDNA.
Endocrinology 1983; 113: 1179-1181
3
B.J Morris – PUBLICATIONS
60.*
Catanzaro DF, Mullins JJ, Morris BJ. The biosynthetic pathway of renin.
Journal of Biological Chemistry 1983; 258: 7364-7368
62.
Zacharatos DT, Vasak EZ, Cheng ESP, van Lennep EW, Morris BJ.
Immunohistochemistry of tonin in rat submandibular gland during
development, lactation and secretion. Histochemistry 1983; 79: 433-442
67.*
Hardman JA, Hort YJ, Catanzaro DF, Tellam JT, Baxter JD, Morris BJ,
Shine J. Primary structure of the human renin gene. DNA 1984; 3: 457-468
70.*
Catanzaro DF, Mesterovic N, Morris BJ. Studies of the regulation of mouse
renin genes by measurement of renin messenger ribonucleic acid.
Endocrinology 1985; 117: 872-878
71.
Morris BJ, Everitt SF. Antihypertensive effect of sialoadenectomy in onekidney, one clip hypertension in the rat. Journal of Hypertension 1985; 3: 601605
74.
Karen P, Morris BJ. Stimulation by thyroid hormone of renin mRNA in mouse
submandibular gland. American Journal of Physiology 1986; 251: E290-E293
75.
Catanzaro DF, Morris BJ. Human cardiac myosin heavy chain genes.
Isolation of a genomic DNA clone and its characterization and of a second
unique clone also present in the human genome. Circulation Research 1986;
59: 655-662
77.
Morris BJ, Taylor JE. Activation by puff adder venom of inactive renin in
normal and hypertensive rat plasma. Clinical and Experimental Pharmacology
& Physiology 1987; 14: 23-31
78.
Henderson BR, Thompson C, Rose BR, Cossart YE, Morris BJ. Detection of
specific types of human papillomavirus in cervical scrapes, anal scrapes and
anogenital biopsies by DNA hybridization. Journal of Medical Virology 1987;
21: 381-393
79.
Rose BR, Thompson CH, McDonald AM, Henderson BR, Cossart YE, Morris
BJ. Cell biology of cultures of anogenital warts. British Journal of
Dermatology 1987; 116: 311-322
81.
Griffiths LR, Nicholson GA, Ross DA, Zwi MB, McLeod JG, Mohandas T,
Morris BJ. Regional chromosomal assignment of human renin gene to
chromosome 1q12qter and use in linkage studies in Charcot-Marie-Tooth
disease. Cytogenetics and Cell Genetics 1987; 45: 231-233
82.*
Schedlich LJ, Bennetts BH, Morris BJ. Primary structure of a human
glandular kallikrein gene. DNA 1987; 6: 429-437
83.
Morris BJ. Molecular weights of renin and inactive renin in mouse plasma.
Journal of Hypertension 1987; 5: 633-634
84.
Morris BJ, Griffiths LR. Frequency in hypertensives of alleles for a RFLP
associated with the renin gene. Biochemical and Biophysical Research
Communications 1988; 150: 219-224
4
B.J Morris – PUBLICATIONS
86.
Katelaris PM, Cossart YE, Rose BR, Thompson CH, Sorich E, Nightingale B,
Dallas PB, Morris BJ. Human papillomavirus: the untreated male reservoir.
Journal of Urology 1988; 140: 300-305
87.
Morris BJ. Triton WR-1339 injected into rats enters renal renin granules.
American Journal of Physiology 1988; 255: E353-E356
91.
Morris BJ, Flanagan JL, McKinnon KJ, Nightingale BN. Papillomavirus
screening of cervical lavages by polymerase chain reaction. Lancet 1988; ii:
1368
92.
Dallas PB, Flanagan JL, Nightingale BN, Morris BJ. Polymerase chain
reaction for fast, nonradioactive detection of high- and low-risk papillomavirus
types in routine cervical specimens and in biopsies. Journal of Medical
Virology 1989; 27: 105-111
95.
Griffiths LR, Board PG, Zwi MB, Morris BJ, McLeod JG, Nicholson GA. The
B subunit of coagulation factor XIII is linked to renin and the Duffy blood
group to -spectrin on human chromosome 1. Human Heredity 1989; 39:
107-109
96.
Qin H, Kemp J, Yip MY, Lam-Po-Tang PRL, Hoh JFY, Morris BJ.
Localization of human cardiac -myosin heavy chain gene (MYH7) to
chromosome 14q12 by in situ hybridization. Cytogenetics and Cell Genetics
1990; 54: 74-76
97.
Morris BJ, Rose BR, Flanagan JL, McKinnon KJ, Loo CY, Thompson CH,
Flampoulidou M, Ford RM, Hunter JC, Nightingale BN, Cossart YE.
Automated polymerase chain reaction for papillomavirus screening of
cervicovaginal lavages: comparison with dot-blot hybridization in a sexually
transmitted diseases clinic population. Journal of Medical Virology 1990; 32:
22-30
102.
Law CLH, Qassim M, Thompson CH, Rose BR, Grace J, Morris BJ, Cossart
YE. Factors associated with clinical and sub-clinical anal human
papillomavirus infection in homosexual men. Genitourinary Medicine 1991;
67: 82-89
103.
Smith DL, Morris BJ. Transient expression analyses of DNA extending 2.4
kb upstream of the human renin gene. Molecular and Cellular Endocrinology
1991; 80: 139-146
104.
Zee RYL, Ying L-H, Morris BJ, Griffiths LR. Association and linkage
analyses of restriction fragment length polymorphisms for human renin and
antithrombin III genes in essential hypertension. Journal of Hypertension
1991; 9: 825-830
106.
Qin H, Kemp J, Yip MY, Lam-Po-Tang PRL, Morris BJ. Localization of
human glandular kallikrein-1 gene to chromosome 19q13.3-13.4 by in situ
hybridization. Human Heredity 1991; 41: 222-226
107.
Ying L-H, Zee RYL, Griffiths LR, Morris BJ. Association of a RFLP for the
insulin receptor gene, but not insulin, with essential hypertension.
Biochemical and Biophysical Research Communications 1991; 181: 486-492
5
B.J Morris – PUBLICATIONS
108.
Lou Y, McKinnon KJ, Ormsby SM, Nightingale BN, Morris BJ. Papillomavirus
DNA and colposcopy instruments. Lancet 1991; 338: 1601-1602
112.
Zee RYL, Lou Y-k, Griffiths LR, Morris BJ. Association of an
insertion/deletion polymorphism of the angiotensin I-converting enzyme gene
with essential hypertension. Biochemical and Biophysical Research
Communications 1992; 184: 9-15
114.
Zee RYL, Morris BJ, Griffiths LR. Association analyses of RFLPs for the 2and  1-adrenoceptor genes in essential hypertension. Hypertension
Research 1992; 15: 57-60
116.
Zee RYL, Griffiths LR, Morris BJ. Marked association of a RFLP for the low
density lipoprotein receptor gene with obesity in essential hypertensives.
Biochemical and Biophysical Research Communications 1992; 189: 965-971
119.
Lou Y-k, Robinson BG, Morris BJ. Renin messenger RNA, detected by
polymerase chain reaction, can be switched on in rat atrium. Journal of
Hypertension 1993; 11: 237-243
122.
Ying L-H, Zee RYL, Griffiths LR, Morris BJ. Non-linkage of insulin receptor
locus with essential hypertension in an affected pedigree. Hypertension
Research 1993; 16: 25-28
123.
Qin H, Chen Y-H, Yip M-Y, Lam-Po-Tang PRL, Morris BJ. Reassignment of
the human renin gene to chromosome 1q32 in studies of a (1;4)(q42;p16)
translocation. Human Heredity 1993; 43: 261-264
124.
Lou Y-k, Qin H., Molodysky E, Morris BJ. Simple microwave and thermal
cycler boiling methods for preparation of cervicovaginal lavage cell samples
prior to PCR for human papillomavirus detection. Journal of Virological
Methods 1993; 44: 77-82
125.
Zee RYL, Lou Y-k, Griffiths LR, Morris BJ. Molecular genetic analyses of
RFLPs for PCR-amplified growth hormone gene, renal kallikrein gene and
atrial natriuretic factor gene in essential hypertension. Hypertension
Research 1993; 16: 113-120
126.
Morris BJ, Zee RYL, Ying L-H, Griffiths LR. Independent, marked
associations of alleles of the insulin receptor and dipeptidyl
carboxypeptidase-1 genes with essential hypertension. Clinical Science
1993; 85: 189-195
127.
Herzog H, Selbie LA, Zee RYL, Morris BJ, Shine J. Neuropeptide-Y Y1
receptor gene polymorphism: Cross-sectional analyses in essential
hypertension and obesity. Biochemical and Biophysical Research
Communications 1993; 196: 902-906
128.
Zee RYL, Lou Y-k, Morris BJ. Insertion variant in intron 9, but not
microsatellite in intron 2, of the insulin receptor gene is associated with
essential hypertension. Journal of Hypertension 1993; 11: 1283-1288
129.
Bennett CL, Schrader AP, Morris BJ. Cross-sectional analysis of
Met235Thr variant of angiotensinogen gene in severe, familial
6
B.J Morris – PUBLICATIONS
hypertension. Biochemical and Biophysical Research Communications 1993;
197: 833-839
132.
Smith DL, Morris BJ, Do YS, Law RE, Shaw KJ, Hsueh WA. Identification of
cyclic AMP response element in the human renin gene. Biochemical and
Biophysical Research Communications 1994; 200: 320-329
134.
Qin H, Morris BJ, Hoh JFY. Isolation and sequence of cat jaw superfast
myosin light chain-2 cDNA and evidence for the identity of its human
homologue. Biochemical and Biophysical Research Communications 1994;
200: 1277-1282
135.
Morris BJ, Zee RYL, Robinson BG. Significant relationships of plasma lipids
and body mass index with polymorphisms at the linked LDL receptor gene and
insulin receptor gene loci (19p13.2) in essential hypertensives. Clinical Science
1994; 86: 583-592
136.* Morris BJ, Zee RYL, Schrader AP. Different frequencies of angiotensin Iconverting enzyme genotypes in older hypertensive individuals. Journal of
Clinical Investigation 1994; 94: 1085-1089
137.
Morris BJ. No difference in substrate affinity of plasma dipeptidyl
carboxypeptidase-1 encoded by the I and D allelic forms of its gene.
Pharmacogenetics 1994; 4: 223-224
138.
Morris BJ, Zee RYL. Dipeptidyl carboxypeptidase-1 gene polymorphism
paradox in hypertension explained by 'deletion depletion'. Journal of
Hypertension 1994; 12: 1199-1200
139.
Smith DL, Law RE, Do Y, Shaw, KJ, Hsueh WA, Morris BJ. Proximal 2.6 kb of
5'-flanking DNA is insufficient for human renin promoter activity in reninsynthesizing chorio-decidual cells. Biochimica et Biophysica Acta 1994; 1219:
465-474
140.
Reid J, Schrader AP, Morris BJ. No effect of kinins on DNA synthesis in
LNCaP prostate cancer cells. Clinical and Experimental Pharmacology and
Physiology 1994; 21: 729-733
145.
Morris BJ, Smith DL, Law RE, Do YS, Shaw KJ, Hsueh WA. Function of
proximal promoter DNA of human renin gene. Kidney International 1994; 46:
1516-1521
146.
Zee RYL, Lou Y-k, Morris BJ. Insertion variant in intron 9, but not
microsatellite in intron 2, of the insulin receptor gene is associated with
essential hypertension. Journal of Hypertension 1994; 12 (suppl 7): S13-S22
149.
Morris BJ, Lee C, Nightingale BN, Molodysky E, Morris LJ, Appio R, Sternhell
S, Mackerras D, Irwig LM. Fourier transform infrared spectroscopy of
dysplastic,
papillomavirus-positive
cervicovaginal
lavage
specimens.
Gynecologic Oncology 1995; 56: 245-249
150.
Zee RYL, Schrader AP, Robinson BG, Griffiths LR, Morris BJ. Association of
HincII RFLP of low density lipoprotein receptor gene with obesity in essential
hypertensives. Clinical Genetics 1995; 47: 118-121
7
B.J Morris – PUBLICATIONS
152.
Smith DL, Jeyapalan S, Lang JA, Guo X-H, Sigmund CD, Morris BJ. Human
renin 5'-flanking DNA to nucleotide –2750. DNA Sequence 1995; 5: 319-321
155.
Lou Y-k, Liu DT, Whitworth JA, Morris BJ. Renin mRNA, quantified by
polymerase chain reaction, in renal hypertensive rat tissues. Hypertension
1995; 26: 656-664
161.* Chambers SM, Morris BJ. Glucagon receptor gene mutation in essential
hypertension. Nature Genetics 1996; 12: 122-122
162.
Schrader AP, Zee RYL, Morris BJ. Association analyses of NsiI RFLP of
human insulin receptor gene in hypertensives. Clinical Genetics 1996; 49: 7478
163.
Lang JA, Ying L-H, Morris BJ, Sigmund CD (1996) Transcriptional and posttranscriptional mechanisms regulate expression of the human renin gene in
Calu-6 cells. American Journal of Physiology 1996; 271: F94-F100
166.
Zee RYL, Schrader AP, Morris BJ. Effect of angiotensin converting enzyme
genotype on renin-angiotensin components in hypertensives. Clinica Chimica
Acta 1996; 252: 33-39
168.* Ying L-H, Morris BJ, Sigmund CD. Transactivation of the human renin
promoter by the cyclic AMP/protein kinase A pathway is mediated by both
cAMP-responsive element binding protein-1 (CREB)-dependent and CREBindependent mechanisms in Calu-6 cells. Journal of Biological Chemistry 1997;
272: 2412-2420
169.
Wang WYS, Zee RYL, Morris BJ. Association of angiotensin II type 1 receptor
gene polymorphism with essential hypertension. Clinical Genetics 1997; 51: 3134
171.
Zee RYL, Stephen AL, Iwai N, Morris BJ. Association analyses of SA gene
variant in essential hypertensives. American Journal of Hypertension 1997; 10:
235-242
172.
Rutherford S, Nyholt DR, Curtain RP, Quinlan SR, Gaffney PT, Morris BJ,
Griffiths LR. Association of a low density lipoprotein receptor microsatellite
variant with obesity. International Journal of Obesity 1997; 21: 1032-1037
173.
Morris BJ, Jeyasingam CL, Zhang W, Curtain RP, Griffiths LR. Influence of
family history on frequency of glucagon receptor Gly40Ser mutation in
hypertensive subjects. Hypertension 1997; 30: 1640-1641
174.
Lou Y-k, Zee RYL, Li M, Morris BJ. Insulin receptor exon 11+/– isoform mRNA
in spontaneously hypertensive and ACTH-hypertensive rats. Journal of
Hypertension 1998; 16: 1009-1014
175.
Sugimura H, Wakai K, Genka K, Nagura K, Igarashi H, Nagayama K, Ohkawa
A, Baba S, Morris BJ, Tsugane S, Ohno Y, You LZ, Takezaki T, Tajima K,
Iwamasa T. Association of Ile462Val (exon 7) polymorphism of cytochrome
P450 IA1 with lung cancer in the Asian population: further evidence from a
case-control study in Okinawa. Cancer Epidemiology, Biomarkers and
Prevention 1998; 7: 413-417
8
B.J Morris – PUBLICATIONS
178.* Benjafield AV, Jeyasingam CL, Nyholt DR, Griffiths LR, Morris BJ. G-protein
3 subunit gene (GNB3) variant in causation of essential hypertension.
Hypertension 1998; 32: 1094-1097
179.
Glenn CL, Wang WYS, Morris BJ. Different frequency of inducible nitric oxide
synthase genotypes in older essential hypertensives. Hypertension 1999; 33:
927-932
180.
Wang WYS, Adams DJ, Glenn CL, Morris BJ. The Gly460Trp variant of adducin is not associated with hypertension in Australian Anglo-Caucasians.
American Journal of Hypertension 1999; 12: 632-636
181.
Stokes GS, Monaghan JC, Schrader AP, Glenn CL, Ryan M, Morris BJ.
Influence of angiotensin converting enzyme (ACE) genotype on interpretation of
diagnostic tests for serum ACE activity. Australian and New Zealand Journal of
Medicine 1999; 29: 315-318
184.
Sugimura H, Kohno T, Wakai K, Nagura K, Genka K, Igarashi H, Morris BJ,
Baba S, Ohno Y, Gao CM, Li ZY, Wang JD, Takezaki T, Tajima K, Varga T,
Sawaguchi T, Lum JK, Martinson JJ, Tsugane S, Iwamasa T, Shinmura K,
Yokota J. hOGG1 Ser326Cys polymorphism and lung cancer susceptibility.
Cancer Epidemiology, Biomarkers and Prevention 1999; 8: 669-674
185.
Wang WYS, Glenn CL, Zhang W, Nyholt DR, Morris BJ. Exclusion of
angiotensinogen locus in molecular basis of human hypertension: Sibpair
linkage and association analyses in Australian Anglo-Caucasians. American
Journal of Medical Genetics 1999; 87: 53-60
186.
Lin RCY, Wang WYS, Morris BJ. High penetrance, overweight, and
glucocorticoid receptor variant: case-control study. BMJ 1999; 319: 1337-1338
187.
Lin RCY, Wang WYS, Morris BJ. Association and linkage analyses of
glucocorticoid receptor gene markers in essential hypertension. Hypertension
1999; 34: 1186-1192
189.
Adams DJ, van der Weyden L, Kovacic A, Lovicu FJ, Copeland NG, Gilbert DJ,
Jenkins NA, Ioannou PA, Morris BJ. Chromosomal localization and
characterization of mouse and human zinc finger protein 265 gene.
Cytogenetics and Cell Genetics 2000; 88: 68-73
190.
Lin RCY, Morris BJ. Polymorphism (1339G>A; A447T) in exon 13 of human
kidney chloride channel gene CLCNKA. Human Mutation 2000; 16: 96 (on-line
report no. 139 – http://humu.edoc.com/1059-7794/pdf/mutation/mpr139.pdf)
191.* Glenn CL, Wang WYS, Benjafield AV, Morris BJ. Linkage and association of
tumor necrosis factor receptor 2 locus with hypertension, hypercholesterolemia,
and plasma shed receptor. Human Molecular Genetics 2000; 13: 1943-1949
192.
Benjafield AV, Morris BJ. Association analyses of endothelial nitric oxide
synthase gene polymorphisms in essential hypertension. American Journal of
Hypertension 2000; 13: 994-998
193.
van der Weyden L, Adams DJ, Morris BJ. Capacity for purinergic control of
renin promoter via P2Y11 receptor and cAMP pathway. Hypertension 2000; 36:
1093-1098
9
B.J Morris – PUBLICATIONS
194.
Morris BJ, Benjafield AV, Ishikawa K, Iwai N. Polymorphism (–173G>A) in
promoter of human epithelial sodium channel gamma subunit gene (SCNN1G)
and association analysis in essential hypertension. Human Mutation 2001; 17:
157 (http://www3.interscience.wiley.com/cgi-bin/abstract/76509101/START)
195.
Lou Yk, Wen C, Li M, Adams DJ, Wang Mx, Yang F, Morris BJ, Whitworth JA.
Decreased renal expression of nitric oxide synthase isoforms in ACTH- and
corticosterone-induced hypertension. Hypertension 2001; 37: 1164-1170
196.
Benjafield AV, Wang XL, Morris BJ. Tumor necrosis factor receptor 2 gene
(TNFRSF1B) in genetic basis of coronary artery disease. Journal of Molecular
Medicine 2001: 79: 109-115
197.
Benjafield AV, Glenn CL, Wang, XL, Colagiuri S, Morris BJ. TNFRSF1B in
genetic predisposition to clinical neuropathy and effect on HDL cholesterol and
glycosylated hemoglobin in type 2 diabetes. Diabetes Care 2001; 24: 753-757
198.
Morris BJ, Glenn CL, Wilcken DEL, Wang XL. Influence of an inducible nitric
oxide synthase promoter variant on clinical variables in patients with coronary
artery disease. Clinical Science 2001; 100: 551-556
199.
Benjafield AV, Lin RCY, Dalziel B, Gosby AK, Caterson ID, Morris BJ. Gprotein 3 subunit gene splice variant in obesity and overweight. International
Journal of Obesity 2001; 25: 777-780
200. * Adams DJ, van der Weyden L, Mayeda A, Stamm S, Morris BJ*, Rasko JEJ.
ZNF265 – A novel spliceosomal protein able to induce alternative splicing.
Journal of Cell Biology 2001; 154: 25-32 (*author for correspondence)
201.
Lin RCY, Ericsson JO, Benjafield AV, Morris BJ. Association of  2adrenoceptor Gln27Glu variant with body weight, but not hypertension.
American Journal of Hypertension 2001; 14: 1201-1204
203.
Morris BJ, Markus MA, Glenn CL, Colagiuri S, Adams DJ, Wang XL.
Association of a functional inducible nitric oxide synthase promoter variant with
complications in type 2 diabetes. Journal of Molecular Medicine 2002; 80: 96104.
204.
Lin RCY, Morris BJ. Association analysis of polymorphisms at the interleukin-1
locus in essential hypertension. American Journal of Medical Genetics 2002;
107: 311-316.
206.
Qin H, Hsu MKH, Morris BJ, Hoh JFY. A distinct subclass of mammalian
striated myosins: Structure and molecular evolution of “superfast” or masicatory
myosin heavy chain. Journal of Molecular Evolution 2002; 55: 1-9.
207.
Lin RCY, Wang XL, Morris BJ. Association of coronary artery disease with
glucocorticoid receptor N363S variant. Hypertension 2003; 41: 404-407.
212.
Zhang Y, Schyvens CG, McKenzie KUS, Morris BJ, Whitworth JA.
Lipopolysaccharide
reverses
adrenocorticotrophic
hormone-induced
hypertension in the rat. Hypertension Research 2003; 26: 427-432.
10
B.J Morris – PUBLICATIONS
213.
Lin RCY, Wang XL, Dalziel B, Caterson ID, Morris BJ. Association of obesity,
but not diabetes or hypertension, with glucocorticoid receptor Asn363Ser
variant. Obesity Research 2003; 11: 802-808.
214.
Kumar NN, Benjafield AV, Lin RCY, Wang WYS, Stowasser M, Morris BJ.
Haplotype analysis of aldosterone synthase gene (CYP11B2) polymorphisms
shows association with essential hypertension. Journal of Hypertension 2003;
21: 1331-1337.
215.
Plambeck CA, Kwan AHY, Adams DJ, Westman BJ, van der Weyden L,
Medcalf RL, Morris BJ, Mackay JP. The zinc finger domain from human
splicing factor ZNF265 forms a novel fold. Journal of Biological Chemistry
2003; 278: 22805-22811.
217.
Lin RCY, Schyvens CG, Wang Y, Whitworth JA, Morris BJ. Tumor necrosis
factor receptor 2 mRNA in rat models of hypertension. American Journal of
Hypertension 2003; 16: 685-688.
218.
Benjafield AV, Iwai N, Ishikawa K, Wang WYS, Morris BJ. Overweight, but
not hypertension, is associated with SAH polymorphisms in Caucasians with
essential hypertension. Hypertension Research 2003; 26: 591-595.
219.
Benjafield AV, Katyk K, Morris BJ. Association of EDNRA, but not WNK4 or
FKBP1B, polymorphisms with essential hypertension. Clinical Genetics 2003;
64: 433-438.
220.* Adams DJ, Beveridge DJ, van der Weyden L, Mangs H, Leedman PJ, Morris
BJ. HADHB, HuR and CP1 bind to the distal 3’-untranslated region of human
renin mRNA and differentially modulate renin expression. Journal of Biological
Chemistry 2003; 278: 44894-44903.
222.
Morris BJ, Lin RCY, Wang XL, Dalziel B, Caterson ID. Central obesity is
associated with glucocorticoid receptor N363S variant: Big picture sheds light.
[Commentary with new data] Obesity Research 2003; 12: 1607-1609.
223.
Speirs HJL, Morris BJ. WNK4 intron 10 polymorphism is not associated with
hypertension. Hypertension 2004: 43: 766-768.
224.
Speirs HJL, Katyk K, Kumar NN, Benjafield AV, Wang WYS, Morris BJ.
Association of G-protein-coupled receptor kinase 4 haplotypes, but not
HSD3B1 or PTP1B polymorphisms, with essential hypertension. Journal of
Hypertension 2004; 22: 931-936.
226.
Blessing EM, Solomon SG, Hashemi-Nezhad M, Morris BJ, Martin PR.
Chromatic and spatial properties of parvocellular cells in the lateral geniculate
nucleus of the marmoset (Callithrix jacchus). Journal of Physiology 2004; 557:
229-245.
227.
Benjafield AV, Wang WYS, Morris BJ. No association of angiotensinconverting enzyme 2 gene (ACE2) polymorphisms with essential
hypertension. American Journal of Hypertension 2004; 17: 624-628.
230.
Adams DJ, van der Weyden L, Gergely FV, Arends M, Martin L, Ng BL,
Tannahill D, Kanaar R, Markus MA, Morris BJ, Bradley A. Targeted
11
B.J Morris – PUBLICATIONS
disruption of BRCTx, a novel centrosomal RAD18-interacting protein.
Molecular and Cellular Biology 2005; 25: 779-788.
232.
Benjafield AV, Wang WYS, Speirs HJL, Morris BJ. Genome-wide scan for
hypertension in Sydney sibships: The GENIHUSS Study. American Journal of
Hypertension 2005; 18: 828-832.
234.
Speirs HJL, Wang WYS, Benjafield AV, Morris BJ. No association with
hypertension of CLCNKB and TNFRSF1B polymorphisms at a hypertension
locus on chromosome 1p36. Journal of Hypertension 2005: 23: 1491-1496.
239.
Morris BJ, Bailis SA, Castellsague X, Wiswell TE, Halperin DT. RACP’s
policy statement on infant male circumcision is ill-conceived. Australian and
New Zealand Journal of Public Health 2006; 30: 16-22.
240.
Markus MA, Morris BJ. Lark is the splicing protein RBM4 and exhibits unique
subnuclear localization properties. DNA and Cell Biology 2006; 25: 457-464.
241. * Markus MA, Heinrich B, Raitskin O, Adams DJ, Mangs H, Goy C, Ladomery
M, Sperling R, Stamm S, Morris BJ. WT1 interacts with the splicing protein
RBM4 and regulates its ability to modulate alternative splicing in vivo.
Experimental Cell Research 2006; 312: 3379-3388.
242. * Mangs H, Speirs HJL, Goy C, Adams DJ, Markus MA, Morris BJ. XE7: A
novel splicing factor that interacts with ASF/SF2 and ZNF265. Nucleic Acids
Research 2006; 34: 4976-4986.
243.* Adams DJ, Head GA, Markus MA, Lovicu FJ, van der Weyden L, Köntgen F,
Arends MJ, Thiru S, Mayorov DN, Morris BJ. Renin enhancer is critical for
regulation of renin gene expression and cardiovascular function. Journal of
Biological Chemistry 2006; 281: 31753-31761.
248.
Yang Z, Venardos K, Jones E, Morris BJ, Chin-Dusting J, Kaye DM.
Identification of a novel polymorphism in the 3’UTR of the L-arginine
transporter gene, SLC7A1 – Contribution to hypertension and endothelial
dysfunction. Circulation 2007; 115: 1269-1274.
252.
Morris BJ, Waskett J, Bailis SA. Case number and the financial impact of
circumcision in reducing prostate cancer. BJU International 2007: 100: 5-6.
253.
Jackson K, Head GA, Morris BJ, Chin-Dusting J, Jones E, La Greca L,
Mayorov DN. Reduced cardiovascular reactivity to stress but not feeding in
renin enhancer knockout mice. American Journal of Hypertension 2007; 20:
893-899.
255.
Stefani M, Markus MA, Lin RCY, Pinese M, Dawes IA, Morris BJ. The effect
on resveratrol on a cell model of human aging. Annals of the New York
Academy of Science 2007: 1114: 407-418.
258. * Markus MA, Goy C, Adams DJ, Lovicu FJ, Morris BJ. Renin enhancer is
crucial for full response in renin expression to an in vivo stimulus.
Hypertension 2007: 50: 933-938.
262.
Martin S, Markus MA, Morris BJ, Davisson RL, Lawrence AJ, van den Buuse
M. Does angiotensin interact with dopaminergic mechanisms in the brain to
12
B.J Morris – PUBLICATIONS
modulate prepulse inhibition in mice? Neuropharmacology 2008; 54: 399404.
272.
Loughlin FE, Mansfield RE, Vaz PM, McGrath AP, Setiyaputra S,
Gamsjaeger R, Chen ES, Morris BJ, Guss JM, Mackay JP. The zinc fingers
of the SR-like protein ZRANB2 are single-stranded RNA-binding domains that
recognize 5' splice site-like sequences. Proceedings of the National Academy
of Science USA 2009; 106: 5581-5586.
273.
Pönighaus C, Speirs HJ, Morris BJ, Kuhn J, Kleesiek K, Götting C.
Xylosyltransferase gene variants and their role in essential hypertension.
American Journal of Hypertension 2009; 22: 432-436.
282.
Marques FZ, Campain AE, Yang JYH, Morris BJ. Meta-analysis of genomewide gene expression differences in onset and maintenance phases of
genetic hypertension. Hypertension 2010: 56: 319-324.
288.
Marques FZ, Pringle KG, Conquest A, Hirst JJ, Markus MA, Sarris M, Zakar
T, Morris BJ, Lumbers ER. Molecular characterization of renin-angiotensin
system components in human intrauterine tissues and fetal membranes from
vaginal delivery and cesarean section. Placenta 2011; 32: 214-221.
291. * Marques FZ, Campain AE, Davern PJ, Yang YHJ, Head GA, Morris BJ.
Genes influencing circadian differences in blood pressure in hypertensive
mice. PLoS ONE 2011; 6: e19203.
292. * Marques FZ, Campain AE, Davern PJ, Yang YHJ, Head GA, Morris BJ.
Global identification of genes and pathways differentially expressed in
hypothalamus in early and established neurogenic hypertension. Physiol
Genomics 2011; 43: Epub ahead of print 12 Apr.
xxx.
Wang EY, Pringle KG, Sykes SD, Marques FZ, Morris BJ, Zakar T, Lumbers
ER. Fetal sex affects expression of renin-angiotensin system components in
human decidua. 2011: submitted.
xxx. * Marques FZ, Campain AE, Yang JYH, Zukowska-Szczechowska E,
Tomaszewski M, Charchar F, Morris BJ. Novel insights into essential
hypertension etiology, revealed by genome-wide gene expression profiling of
human kidneys: evidence for a microRNA-mediated effect on renin
expression. Manuscript close to completion for submission to major journal.
xxx.
Markus MA,Marques FZ, Morris BJ. Resveratrol, by modulating the
expression of RNA processing factors, can influence the alternative splicing
of pre-mRNAs. Submitted.
INVITED REVIEWS IN INTERNATIONAL JOURNALS
16.
Reid IA, Morris BJ, Ganong WF. The renin-angiotensin system. Annual
Review of Physiology 1978; 40: 377-410
13
B.J Morris – PUBLICATIONS
73.
Morris BJ. New possibilities for intracellular renin and inactive renin now that
the structure of the human renin gene has been elucidated. Clinical Science
1986; 71: 345-355
99.
Morris BJ. Molecular genetics links renin to hypertension. Molecular and
Cellular Endocrinology 1991; 75:C13-C18
110.
Morris BJ. Molecular biology of renin. I: Gene and protein structure,
synthesis and processing. Journal of Hypertension 1992; 10: 209-214
111.
Morris BJ. Molecular biology of renin. II: Gene control by messenger RNA,
transfection and transgenic studies. Journal of Hypertension 1992; 10: 337342
118.
Morris BJ. Identification of essential hypertension genes. Journal of
Hypertension 1993; 11: 115-120
182.
Morris BJ Molecular genetics in childhood hypertension. Progress in
Pediatric Cardiology 1999; 9: 203-212
210.
Morris BJ. Renin: from ‘pro’ to promoter. BioEssays 2003: 25: 250-227
216.
Morris BJ, Benjafield AV, Lin RCY. Essential hypertension: genes and
dreams. Clinical Chemistry and Laboratory Medicine 2003; 41: 834-844.
229.
Morris BJ. The scorching breath of angiotensin. [Editorial Commentary]
Journal of Hypertension 2005; 23: 33-35.
231.
Morris BJ. Angiotensin receptor gene variant goes with the flow. [Editorial
Commentary] Journal of Hypertension 2005; 23: 707-709
233.
Morris BJ. A forkhead in the road to longevity: the molecular basis of
lifespan becomes clearer. Journal of Hypertension 2005: 23: 1285-1309
(**Top download for this journal in 2005 after a clinical guidelines article that
was the most downloaded article for the entire biomedical literature published
in that year).
236.
Everitt AV, Hilmer SN, Brand-Miller JC, Jamieson HA, Truswell AS, Sharma
AP, Mason RS, Morris BJ, Le Couteur DG. Dietary approaches that delay
age-related diseases. Clinical Interventions in Aging 2005; 1: 11-31.
237.
Morris BJ. Cervical human papillomavirus screening by PCR: Advantages of
targeting the E6/E7 region. Clinical Chemistry and Laboratory Medicine 2005:
43: 1171-1177.
238.
Morris BJ. Dissecting hypertension by obesity identifies a locus at 1p36.
[IEditorial Commentary] Hypertension 2005; 46: 1256-1258.
247.
Morris BJ. Climate not cultivars in the NO-ing of red wines. [Editorial
Commentary] Journal of Hypertension 2007; 25: 501-503.
249.
Mangs AH, Morris BJ. The human pseudoautosomal region (PAR): origin,
function and future. Current Genomics 2007; 8: 129-136.
14
B.J Morris – PUBLICATIONS
250.
Morris BJ, Rose BR. Cervical screening in the 21st century: The case for
human papillomavirus testing of self-collected specimens. Clinical Chemistry
and Laboratory Medicine 2007: 45: 577-591.
256.
Morris BJ. Why circumcision is a biomedical imperative for the 21st century.
BioEssays 2007: 29: 1147-1158.
264.
Markus MA, Morris BJ. Resveratrol in prevention and treatment of common
clinical conditions of ageing. Clinical Interventions in Ageing 2008: 3: 331339.
265.
Mangs AH, Morris BJ. ZRANB2: Structural and functional insights into a
novel splicing protein. International Journal of Biochemistry and Cell Biology
2008;.40: 2353-2357.
265.
Wamai RG, Weiss HA, Hankins C, Agot K, Karim QA, Shisana O, Bailey RC,
Betukumesu B, Bongaarts J, Bowa K, Cash R, Cates W, Diallo MO, Dludlu S,
Geffen N, Heywood M, Jackson H, Kayembe PK, Kapiga S, Kebaabetswe P,
Kintaudi L, Klausner JD, Leclerc-Madlala S, Mabuza K, Makhubele MB,
Miceni K, Morris BJ, de Moya A, Ncala J, Ntaganira I, Nyamucherera OF
Otolorin EO, Pape JW, Phiri M, Rees H, Ruiz M, Sanchez J, Sawires S,
Seloilwe ES, Serwadda DM, Setswe G, Sewankambo N, Simelane D, Venter
F, Wilson D, Woelk G, Zungu N, Halperin DT. Male circumcision is an
efficacious, lasting and cost-effective strategy for combating HIV in highprevalence AIDS epidemics: Time to move beyond debating the science.
[Most authors listed alphabetically] Future HIV Therapy 2008; 2: 399-405.
268.
Morris BJ. GRK4 genetics and response to beta-blocker. [Editorial
Commentary] American Journal of Hypertension 2009; 22: 235-236.
269.
Markus MA, Morris BJ. RBM4: a multifunctional RNA-binding protein.
International Journal of Biochemistry and Cell Biology 2009: 41: 740-743.
274.
Morris BJ. Might a leptin gene variant affect blood pressure of obese
Brazilians? [Editorial Commentary] American Journal of Hypertension 2009;
22: 467.
276.
Marques FZ, Markus MA, Morris BJ. Resveratrol: Cellular actions of a potent
natural chemical that confers a diversity of health benefits. International
Journal of Biochemistry and Cell Biology 2009: 41: 2125-2128.
277.
Marques FZ, Markus MA, Morris BJ. Molecular mechanism of longevity and
clinical implications. Maturitis 2010: 65: 87-91.
278.
Morris BJ. Sympathetic meta-analysis of adrenoceptor gene variants in
hypertension. [Editorial Commentary] American Journal of Hypertension
2010; 23: 225.
279.
Marques FZ, Markus MA, Morris BJ. Hormesis as a pro-healthy aging
intervention in human beings? Dose Response 2010: 8: 28-33.
283.
Cooper DA, Wodak AD, Morris BJ. The case for boosting infant male
circumcision in the face of rising heterosexual transmission of HIV. (Invited
Editorial) Med J Aust 2010; 193: 318-319.
15
B.J Morris – PUBLICATIONS
279.
Marques FZ, Morris BJ. Commentary on resveratrol and hormesis:
Resveratrol – a hormetic marvel in waiting? [Editorial Commentary] Human
and Experimental Toxicology 2010: 29: 1026-1028.
290.
Morris BJ. Renin, genes, and beyond: 40 years of molecular discoveries in
the hypertension field. (Lewis K. Dahl Memorial Lecture) Hypertension 2011;
57(part 2): 538-548
294.
Morris BJ, Gray RH, Castellsague X, Bosch FX, Halperin DT, Waskett JH,
Hankins CA. The strong protection afforded by circumcision against cancer
of the penis. (Invited) Adv Urol 2011: Article ID 812368: 1-21.
296.
Morris BJ, Waskett JH, Gray RH, Halperin DT, Wamai R, Auvert B, Klausner
KD. Exposé of misleading claims that male circumcision will increase HIV
infections in Africa. 2011: accepted 1 Jun.
xxx.
Wamai R, Morris BJ, Bailis SA, Sokal D, Klausner JA, Appleton R,
Sewankambo N, Cooper DJ, Bogaarts J, de Bruyn G, Wodak A. Male
circumcision for HIV prevention – an update on the science and
implementation in generalized epidemics. J Int AIDS Soc 2011: in revision.
xxx.
Morris BJ, Wamia R. Biological basis for the protective effect conferred by
male circumcision against HIV infection. 2011: submitted
xxx.
Morris BJ, Wodak AD, Schrieber L, Willcourt RJ. RACP’s 2010 policy
statement on infant male circumcision is not evidence-based and is
detrimental to public health. in preparation
INVITED REVIEWS PUBLISHED AS CHAPTERS IN BOOKS
131.
Morris BJ, Lou Y-k. Cardiac renin, gene expression and regulation. In:
Lindpaintner K, Ganten D, eds, Cardiac Renin-Angiotensin System, Futura
Medical Publishers, New York, 1994, pp. 21-45.
157.
Morris BJ. Molecular biology of renin. In: Ganten D, Lindpaintner K,
Molecular Reviews in Cardiovascular Medicine, Rapid Science Publishers,
London, 1996, pp. 12-32.
158.
Morris BJ. Discovery of genes for essential hypertension. In: Ganten D,
Lindpaintner K, Molecular reviews in Cardiovascular Medicine Rapid Science
Publishers, London, 1996, pp. 33-48.
183.
Morris BJ. Genes for essential hypertension: The first decade of research.
In: Progress in Hypertension, Volume 4: Molecular, Genetic and Immune
Predisposition to Hypertension, eds Frossard PM, Parvez SH, Minami M,
Parvez S, Saito H, VSP International Press, Zeist, The Netherlands, 1-44,
1999.
188.
Morris BJ. Renin. In: Handbook of Physiology. Section 7, The Endocrine
System. Volume III, Endocrine Regulation of Water and Electrolyte Balance.
16
B.J Morris – PUBLICATIONS
Fray JCS, volume ed, Goodman HM, section ed. American Physiological
Society, Oxford University Press, New York, 2000, pp. 3-58.
259.
Morris BJ. How xenohormetic compounds confer health benefits. In: Le
Bourg E, Rattan SIS (eds). Mild Stress: Applying Hormesis in Aging
Research and Interventions. Springer, Netherlands. 2008, pp. 115–138.
260.
Abete P, Calabrese E, Ji LL, Kristensen T, Le Bourg E, Loeschcke V, Morris
B, Rengo F, Rattan SIS, Safwat A, Sarup P, Sorensen J, Vaiserman AM.
Mild stress and healthy aging: Perspectives for human beings. In: Le Bourg
E, Rattan SIS (eds), Mild Stress and Healthy Aging. Applying Hormesis in
Aging Research and Therapy. Springer, Netherlands. 2008, pp. 171–183.
280.
Morris BJ. Calorie restriction mimetics and ageing. In: Everitt AV, Rattan
SIS, Le Couteur DG, de Cabo R, eds. Calorie Restriction, Aging and
Longevity. Springer, Dordrecht, Netherlands. 2010, pp. 141-175.
281.
Everitt AV, Heilbronn LK, Morris BJ, Brown-Borg HM, Merry BJ, Simpson
SJ, Varady KA, Masoro EJ, Redman LM, Le Couteur DG. Conclusion:
Human calorie restriction and anti-ageing therapy. In: Everitt AV, Rattan SIS,
Le Couteur DG, de Cabo R, eds. Calorie Restriction, Aging and Longevity.
Springer, Dordrecht, Netherlands. 2010, pp. 311-318.
293.
Morris BJ, Castellsague X. The role of circumcision in prevention of sexually
transmitted infections. Gross GE, Tyring S, eds. Sexually Transmitted
Diseases. Springer, Heidelberg. 2011, pp. 311-318.
xxx.
Morris BJ, Eley C. Male circumcision: An appraisal of current
instrumentation. In: Biomedical Engineering. InTech (open access publisher),
University STeP Ri, Croatia: accepted 18 Apr 2011; proof returned 20 May
for publication June/July (40 pp).
xxx.
Cox G, Morris BJ. Why circumcision From pre-history to the 21st century.
Bolnick DA, Koyle MA, Yosha A, eds. Surgical Guide to Circumcision.
Springer, London 2010: accepted.
xxx.
Morris BJ, Cox G. Current medical evidence favours male circumcision.
Bolnick DA, Koyle MA, Yosha A, eds. Surgical Guide to Circumcision.
Springer, London, 2010: accepted.
REFEREED JOURNAL ARTICLES AND BOOK CHAPTERS
INVITED FOR SUBMISSION AT CONFERENCES
2.
Johnston CI, Mendelsohn FAO, Hutchinson JS, Morris BJ. Composition of
juxtaglomerular granules isolated from rat kidney cortex. In: Sambhi MP (ed):
Mechanisms of Hypertension. Elsevier, Amsterdam: Excerpta Medica,
International Congress Series 1973; 302: 238-248
17
B.J Morris – PUBLICATIONS
4.
Johnston CI, Hutchinson JS, Morris BJ, Dax EM. Release and clearance of
neurophysins and posterior pituitary hormones. Annals of the New York
Academy of Sciences 1975; 248: 272-280
6.
Morris BJ, Dax EM, Cumming IA, Lawson RAS, Hutchinson JS, Johnston CI.
Neurophysins: secretion into the circulation and metabolism by renal
lysosomes. In: Rein et Foi, Maladies de la Nutrition. Journées Internationales
de Néphrologie, Vittel 1974 , Vol. 16B, 1976, pp. 621-634
11.
Holdsworth S, McLean A, Morris BJ, Dax E, Johnston CI. Renin release
from isolated rat glomeruli. (Paper arising from the International Society of
Hypertension [ISH] meeting in 1976) Clinical Science and Molecular Medicine
1976; 51: 97s-99s
36.
Morris BJ, Lawrence CH, Catanzaro DF. Activation of plasma prekallirein
and inactive renin by puff addrer venom. Clinical and Experimental
Pharmacology & Physiology 1980; 7: 563-567
43.
Morris BJ, Catanzaro DF. Biosynthesis of preprorenin and intracellular
conversion of prorenin to renin. (Proceedings of the HBPRCA meeting in
1980) Clinical and Experimental Pharmacology & Physiology 1981; 8: 441445
45.
Morris BJ, Catanzaro DF, Richards RI, Mason A, Shine J. Kallikrein and
renin: Molecular biology and biosynthesis. (Paper arising from ISH meeting in
1981) Clinical Science 1981; 61 (Suppl. 7): 351s-353s.
49.
Morris BJ, Catanzaro DF, Cam GR. Renin synthesis and gene cloning.
(Proceedings of the HBPRCA meeting in 1982) Clinical and Experimental
Pharmacology & Physiology Suppl. 1982; 7: 9-19.
50.
Morris BJ, Catanzaro DF, Cam GR, Charnock PP, Baker AR, Shine J.
Identification of bacterial colonies expressing cloned recombinant DNA
coding for renin. Paper arising from ISH meeting in 1982) Clinical Science
1982; 63 (Suppl. 8): 147s-148s
51.
Catanzaro DF, BJ Morris. Biosynthesis of preprorenin. Studies using whole
tissue, a cell-free system, and E. coli containing cDNA inserted at the PstI
site of plasmid pBR322. Clinical and Experimental Hypertension 1982; A4:
1939-1963.
57.
Catanzaro DF, Baker AR, Cam GR, Morris BJ. Immunoscreening of
expression clones using antibodies to renin, EGF and NGF. In: Nagley P,
Linnane AW, Peacock WJ, Pateman JA (eds) Manipulation and Expression
of Genes in Eukaryotes. Academic Press Australia, Sydney, 1983, pp. 11-12
58.
Morris BJ, Catanzaro DF, Mullins JJ, Hardman J, Shine J. Synthesis of
mouse renin as a 2-5-33-5 kilodalton pre-pro-two-chain molecule and use of
its cDNA to identify the human gene. (Proceedings of the HBPRCA meeting
in 1982) Clinical and Experimental Pharmacology & Physiology 1983; 10:
293-297
63.
Morris BJ, Catanzaro DF, Hardman J, Mesterovic N, Tellam J, Hort Y,
Bennetts BH, Shine J. Structure of human renin and expression of the renin
18
B.J Morris – PUBLICATIONS
gene. Clinical and Experimental Pharmacology & Physiology 1984; 11: 369373
64.
Morris BJ. Molecular biology of renin. In: Doyle AE, Mendelsohn FAO (eds):
Receptors, Membranes and Transport Mechanisms in Medicine. Elsevier,
Amsterdam: Excerpta Medica, International Congress Series 1984; 660: 157173.
65.
Morris BJ, Catanzaro DF, Hardman J, Mesterovic N, Tellam J, Hort Y,
Shine J. Human renin gene sequence, gene regulation and prorenin
processing. Journal of Hypertension 1984; 2 (suppl. 3): 231-233.
66.
Shine J, Hardman JA, Hort YJ, Tellam JT, Catanzaro DF, Morris BJ, Baxter
JD. Structure of the human renin gene. Transactions of the Association of
American Physicians 1984; 97: 63-69.
68.
Catanzaro DF, O'Connell AM, Morris BJ. Isolation of genomic clones coding
for the heavy chains of two human cardiac myosins. (Proceedings of the
HBPRCA meeting in 1984) Clinical and Experimental Pharmacology &
Physiology 1985; 12: 295-297.
69.
Morris BJ, Guss JM, Hunter WN, Catanzaro DF. A structural analysis of
human renin. (Proceedings of the HBPRCA meeting in 1984) Clinical and
Experimental Pharmacology & Physiology 1985; 12: 299-304.
72.
Morris BJ, Catanzaro DF. Evolution of renin. (Proceedings of the HBPRCA
meeting in 1985) Clinical and Experimental Pharmacology & Physiology
1986; 13: 365-370.
76.
Morris BJ, Catanzaro DF, Schedlich LJ, Gilchrist AS, Burger JB. Genes for
regulation of human blood pressure. Journal of Hypertension 1986; 4 (suppl.
6): S84-S86
80.
Morris BJ, Pinet F, Michel J-B, Soubrier F, Corvol P. Renin secretion from
malignant pulmonary metastatic tumour cells of vascular origin. (Proceedings
of the HBPRCA meeting in 1986) Clinical and Experimental Pharmacology &
Physiology 1987; 14: 227-231
85.
Schedlich LJ, Morris BJ. Three Alu repeated sequences associated with a
human glandular kallikrein gene. (Proceedings of the HBPRCA meeting in
1987) Clinical and Experimental Pharmacology & Physiology 1988; 15: 339344
89.
Smith DL, Morris BJ. Human renin gene: extended sequence of 5'-flanking
DNA and its linkage to CAT gene for studies of regulation. (International
Symposium on Mechanisms and Management of Hypertension, A Satellite of
the 10th International Congress of Pharmacology in 1987 – A Festchrift to
Austin Eric Doyle, AO) Clinical and Experimental Hypertension 1988; A10:
1309-1311
90.
Schedlich LJ, Catanzaro DF, Morris BJ. Kallikrein genes: cloning in man and
expression in rat renal hypertension. (Paper arising from ISH meeting in
1988) Journal of Hypertension 1988; 6 (suppl. 4): S395-S398
19
B.J Morris – PUBLICATIONS
93.
Morris BJ. Human renin protein and gene structures: present and future
targets for renin blockade in treatment of hypertension. (Paper arising from
ISH meeting in 1988) Journal of Hypertension 1989; 6 (suppl. 2): S9-S14
94.
Morris BJ. hGK-1: a kallikrein gene expressed in human prostate.
(Proceedings of the HBPRCA meeting in 1988) Clinical and Experimental
Pharmacology & Physiology 1989; 16: 345-351
100.
Lou Y-k, Smith DL, Robinson BG, Morris BJ. Renin gene expression in
various tissues determined by single-step polymerase chain reaction.
(Proceedings of the HBPRCA meeting in 1990) Clinical and Experimental
Pharmacology and Physiology 1991; 18: 357-362
101.
Griffiths LR, Zee RYL, Ying L-H, Morris BJ. A locus on the long arm of
chromosome 1 as a possible cause of essential hypertension. (Proceedings
of the HBPRCA meeting in 1990) Clinical and Experimental Pharmacology
and Physiology 1991; 18: 363-366
105.
Morris BJ, Smith DL. Prorenin and gene activation. (Paper arising from ISH
Satellite Symposium: 'Activation and Function of Prorenin') Canadian Journal
of Physiology and Pharmacology 1991; 69: 1367-1374
115.
Berg T, Bradshaw RA, Carretero OA, Chao J, Chao L, Clements JA,
Fahnestock M, Fritz H, Gauthier F, MacDonald RJ, Margolias HS, Morris BJ,
Richards RI, Scicli AG. A common nomenclature for members of the tissue
(glandular) kallikrein gene families. In: Fritz H, Müller-Esterl W, Jochum M,
Roscher A, Luppertz K (eds): Recent Progress on Kinins: Biochemistry and
Molecular Biology of the Kallikrein-Kinin System. Agents and Actions
Supplements, vol. 1, Birkhäuser Verlag, Basel, 1992; pp. 19-25
120.
Morris BJ. Chromosome 17q23: a locus for cardiovascular disease.
(Proceedings of the HBPRCA meeting in 1992) Clinical and Experimental
Pharmacology and Physiology 1993; 20: 279-282
121.
Loudon JA, Fukamizu A, Murakami K, Morris BJ. Species differences in
binding of submandibular nuclear proteins to renin promoter DNA.
(Proceedings of the HBPRCA meeting in 1992) Clinical and Experimental
Pharmacology and Physiology 1993; 20: 283-288
130.
Morris BJ. Molecular genetic studies in patients with severe, familial
hypertension. Iyaku Journal 1994; 30: 1038-1045
133.
Morris BJ, Monaghan JC, Perich R, Stokes GS, Jackson B, Schrader AP.
Genotypic influence on plasma dipeptidyl carboxypeptidase-1 activity in
hypertensives. (Proceedings of the HBPRCA meeting in 1993) Clinical and
Experimental Pharmacology and Physiology 1994; 21: 343-346
143.
Morris BJ, Zee RYL. Similarity of blood pressure for each genotype of the
insertion/deletion polymorphism of the dipeptidyl carboxypeptidase-1 gene in
different age groups of patients with severe, familial essential hypertension.
(Proceedings of the HBPRCA meeting in 1993) Clinical and Experimental
Pharmacology and Physiology 1994; 21: 919-924
144. Zee RYL, Bennett CL, Schrader AP, Morris BJ. Frequencies of variants of
candidate genes in different age groups of hypertensives. (Proceedings of the
20
B.J Morris – PUBLICATIONS
HBPRCA meeting in 1993) Clinical and Experimental Pharmacology and
Physiology 1994; 21: 925-930
153. Lou Y-k, Liu DT, Whitworth JA, Morris BJ. Renin mRNA concentration in
hypothalamus is decreased by enalapril. (Proceedings of the HBPRCA
meeting in 1994) Clinical and Experimental Pharmacology and Physiology
1995; 22: 493-495
154. Griffiths LR, Curtain RP, Nyholt DR, Zee RYL, Morris BJ. Cross-sectional
study of a microsatellite marker in the low density lipoprotein receptor gene in
obese normotensives. (Proceedings of the HBPRCA meeting in 1994) Clinical
and Experimental Pharmacology and Physiology 1995; 22: 496-498
156. Morris BJ. Some physiological outcomes of renin gene studies. [Invited
Review arising from Joint Meeting of the Australian Physiological and
Pharmacological Society and the Endocrine Society of Australia) Clinical and
Experimental Pharmacology and Physiology 1995; 22: 966-975
159. Morris BJ. An angiotensin converting enzyme genotype, present in one in
three Caucasians, is associated with an increased mortality rate. (Invited
Review arising from HBPRCA meeting in 1995) Clinical and Experimental
Pharmacology and Physiology 1996; 23: 1-10
164. Friend LR, Morris BJ, Gaffney PT, Griffiths LR. Examination of the role of
nitric oxide synthase and renal kallikrein as candidate genes for essential
hypertension. (Proceedings of the HBPRCA meeting in 1995) Clinical and
Experimental Pharmacology and Physiology 1996; 23: 564-566
165. Lou Y-k, Zee RYL, Li M, Morris BJ. No difference in the proportion of insulin
receptor exon 11 +/– isoform mRNA in the liver of rats after development of
hypertension. (Proceedings of the HBPRCA meeting in 1995) Clinical and
Experimental Pharmacology and Physiology 1996; 23: 602-604
167. Morris BJ, Chambers SM. Glucagon receptor glycine to serine missense
mutation contributes to one in 20 cases of essential hypertension.
(Proceedings of the HBPRCA meeting in 1995) Clinical and Experimental
Pharmacology and Physiology 1996; 23: 1035-1037
170. Morris BJ. Insulin receptor gene in hypertension. (Invited Review arising from
IInd Franco-Australian Hypertension Meeting) Clinical and Experimental
Hypertension 1997; 19: 551-565
176. Rutherford S, Boatwright SD, Samwell G, Morris BJ, Griffiths LR. A linkage
and association study of hypertension and obesity using a poly(A) Alu repeat
polymorphism at the glucagon receptor gene locus (17q25). (Proceedings of
the HBPRCA meeting in 1997) Clinical and Experimental Pharmacology and
Physiology 1998; 25: 25: 627-629
177. Morris BJ, Griffiths LR. Scanning the genome for essential hypertension loci.
[Invited Review arising from Fetschrift for John P. Coghlan] Clinical and
Experimental Pharmacology and Physiology 1998; 25 (suppl): S72-S78
202. Morris BJ, Adams DJ, van der Weyden L. Renin gene expression: the switch
and the fingers. (Issue devoted to IIIrd Franco-Australian Hypertension Meeting
21
B.J Morris – PUBLICATIONS
in 2000) Clinical and Experimental Pharmacology and Physiology 2001; 28:
1044-1047
228. Morris BJ, Adams DJ, Beveridge DJ, van der Weyden L, Leedman PJ. Cyclic
AMP controls human renin mRNA stability via specific RNA binding proteins.
(Invited review arising from 10th APS International Symposium: Functional
Genomics of the Juxtaglomerular Apparatus) Acta Physiologica Scandanavica
2004; 181: 369-373.
263. Morris BJ. Fluorescence activated cell sorting of transiently transfected As4.1
cells shows renin enhancer directs on/off switching of renin promoter in vitro.
(Original research from invited symposium paper at IVth Franco-Australian
Meeting on Hypertension in 2007) Clinical and Experimental Pharmacology
and Physiology 2008: 35: 367-371.
LETTERS TO THE EDITOR PUBLISHED IN JOURNALS
205. Morris BJ. Critique of “Chromosome 17 and the inducible nitric oxide synthase
gene in human essential hypertension” by Rutherford et al., Human Genetics,
published online September 2001. Human Genetics 2002; 110: 98-99
211. Morris BJ. [Critique of:] Circumcision for phimosis and other medical
indications. Medical Journal of Australia 2003; 178: 588-589.
221. Morris BJ, Lin RCY, Wang XL. Response to: Glucocorticoid receptor gene
and coronary artery disease: Right idea, wrong gene variant? Hypertension
2003; 42: e3-e4.
225. Morris BJ, Bailis SA. Circumcision rate too low? Australian and New Zealand
Journal of Surgery 2004; 74: 386-387.
235. Morris BJ. Critique of “Sibpair Studies Implicate Chromosome 18 in Essential
Hypertension” by S. Rutherford, M.P. Johnson and L.R. Griffiths. Am J Med
Genet 126A:241-247 (2004) American Journal of Medical Genetics 2005;
132A: 456-457.
245. Morris BJ, Castellsague X, Bailis SA. Re: Cost analysis of neonatal
circumcision in a large health maintenance organization. E. J. Schoen, C. J.
Colby and T. T. To. J Urol, 175: 1111-1115, 2006. Journal of Urology 2006;
176: 2315-2316.
246. Morris BJ. Circumcision in Australia: prevalence and effects on sexual health.
International Journal of STD & AIDS 2007: 18: 69-70.
251. Waskett JH, Morris BJ. Fine-touch pressure thresholds in the adult penis.
BJU International 2007; 99: 1551-1552.
261. Waskett J, Morris BJ. Re: ‘RS Van Howe, FM Hodges. The carcinogenicity of
smegma: debunking a myth.’ An example of myth- and mythchief-making?
Journal of the European Academy of Dermatology and Venereology 2008; 22:
131-132.
22
B.J Morris – PUBLICATIONS
270. Waskett JH, Morris BJ, Weiss HA. Errors in meta-analysis by Van Howe.
International Journal of STD & AIDS 2009: 20: 216-218.
275. Morris BJ, Bailis SA, Waskett JH, Wiswell TW, Halperin DT. Medicaid
coverage of newborn circumcision: A health parity right of the poor. American
Journal of Public Health 2009; 99: 969-971.
285. Gray RH, Bailey RC, Morris BJ. Keratinization of the adult male foreskin and
implications for male circumcision. AIDS 2010: 24: 1381.
286. Morris BJ, Wodak A. Circumcision survey misleading. Aust NZ J Public Health
2010; 34: 636-637.
287. Cooper DA, Wodak AD, Morris BJ. The case for boosting infant male
circumcision in the face of rising heterosexual transmission of HIV – In Reply.
(Invited) Med J Aust 2011; 194:101
289. Banerjee J, Klausner JD, Halperin DT, Wamai R, Schoen EJ, Moses S, Morris
BJ, Bailis SA, Venter F, Martinson N, Coates TJ, Gray G, Bowa K.
Circumcision denialism unfounded and unscientific. [Critique of Green et al.,
“Male circumcision and HIV prevention: Insufficient evidence and neglected
external validity”] Am J Prevent Med 2011: 40: e11-e12.
295. Wamai R, Morris BJ. “How to contain generalized HIV epidemics” article is
misconstrued. Int J STD AIDS 2011: accepted 13 Dec 2010; proof returned
Feb 2011.
BRIEF COMMUNICATIONS
18.
Morris BJ, Day RP. Activation of inactive renin by kallikrein. IRCS Medical
Sciences 1978; 6: 348.
19.
Reid IA, Moffat B, Morris BJ. Two forms of angiotensinogen in dog
cerebrospinal fluid. IRCS Medical Sciences 1978; 6: 383.
22.
Morris BJ, Day RP. Activation of inactive renin by fibrinolysin. IRCS Medical
Sciences 1979; 7: 188.
23.
Morris BJ, Reid IA. Difference in immunochemical properties of dog
angiotensinogens in plasma and cerebrospinal fluid. IRCS Medical Sciences
1979; 7: 194.
24.
Lawrence CH, Morris BJ. Activation of inactive renin in human plasma by puff
adder venom. IRCS Medical Sciences 1979; 7: 208.
31.
Catanzaro DF, Morris BJ. Cell-free biosynthesis of renin precursor and
activation by kallikrein and trypsin. Morris BJ, Day RP. Activation of inactive
renin by fibrinolysin. IRCS Medical Sciences 1980; 8: 495-496.
32.
Morris BJ, Catanzaro DF. Activation of inactive renin by nerve growth factor.
IRCS Medical Sciences 1980; 8: 433.
23
B.J Morris – PUBLICATIONS
34.
McGirr JG, Morris BJ. Effect of selective inactivation of plasma kallikrein by
Pro-Phe-CH2Cl on the alkaline phase of acid activation of inactive renin in
human plasma. IRCS Medical Sciences 1980; 8: 683-684.
35.
Morris BJ, de Zwart RT, Brown CR. Activation of inactive renin by acrosin.
IRCS Medical Sciences 1980; 8: 721.
38.
Catanzaro DF, Morris BJ. Evidence for a prepro--nerve growth factor (Mr
25000). IRCS Medical Sciences 1981; 9: 52-53.
40.
Roper KJ, Morris BJ. Hypertension-producing substance in kidney extracts.
IRCS Medical Sciences 1981; 9: 393
42.
Cheng ESP, Morris BJ. Activation of inactive renin by tonon. IRCS Medical
Sciences 1981; 9: 1113.
48.
Cheng ESP, Everitt SF, Morris BJ. Anti-hypertensive effect of sialoadenectomy
in rats with renal hypertension. IRCS Medical Sciences 1982; 10: 211.
61.
Charnock PP, Morris BJ. Evidence for a preprotonin (Mr 35 000). IRCS
Medical Sciences1983; 11: 238-239.
88.
Burger JB, Hayes G, Schedlich LJ, Hoh JFY, Morris BJ. Differential
hybridization of DNA of each human cardiac myosin heavy chain gene to atrial
and ventricular RNA. Medical Science Research 1988; 16: 1153-1154.
SCHOLARLY MAGAZINES
98.
Morris BJ. The renin gene in hypertension. Today’s Life Science 1990; 2 (11):
36-43.
109. Morris BJ. Hypertension: Insulin receptor locus implicated. Today’s Life
Science 1992; Feb: 50-52.
113. Morris BJ. Hypertension: ACE locus implicated. Today’s Life Science 1992;
May: 45-46.
117. Morris BJ. Obesity: LDL receptor gene implicated. Today’s Life Science 1993;
Jan: 42-43.
147. Morris BJ. ACE death genotype affects one-third of population. Lab News
1994; Nov: 9-12.
151. Morris BJ. ACE of spades: A death gene dealt by Mother Nature. Today’s Life
Science 1995; Jan: 20-22.
156. Morris BJ. ACE of spades: A death allele of the ACE gene. Upbeat 1995: 4-7.
208. Morris BJ. Drugs capable of increasing lifespan. Guild Bulletin 2003; Mar: 28.
24
B.J Morris – PUBLICATIONS
209. Morris B. Scientists mix up a recipe for human longevity. Australian Doctor
2003; 18 Apr: 40-41.
254. Morris BJ. An old protector mandated – circumcision. HPV Today 2007; (13):
12-13. (Invited)
257. Morris BJ. Circumcision facts trump anti-circ fiction. The Skeptic 2007; 27 (4):
52-56.
264. Morris BJ. Circumcision: who should you believe? The Skeptic 2008; 28 (2):
55-58.
267. Morris BJ, Halperin DH, Klausner J. Cut! New Scientist 2008; (2670): 20-21.
271. Morris BJ. Male circumcision should be routine. [Invited] Medical Observer 10
Apr 2009, pp 18-19.
INVITED BOOK REVIEW
148. Morris BJ. The Gene Hunters, by W Cookson (1994) Aurum Press, London
(208 pp). Journal of the Royal Society of Medicine 1994; 88: 93-94
MONOGRAPHS
Morris BJ. Hypertension. The Inside Story on this Silent Killer, 1985 (73 pages)
1985. Self-published. ISBN 0 9589371 0 9
Morris BJ. In Favour of Circumcision. [Invited] University of New South Wales
Press, Sydney (104 pages) 1999. ISBN 0 86840 537 X
[Note: Monographs are not included in publication count]
THESES
Morris BJ. Molecular, Physiological and Genetic Studies in Hypertension Research.
DSc Thesis, The University of Sydney, 1992
Morris BJ. The Renin-Angiotensin System in Kidney Cells. PhD Thesis, Monash
University and The University of Melbourne, 1975
Morris BJ. The Mechanism of Activation of Renin in Human Amniotic Fluid.
BSc(Hons) Thesis, The University of Adelaide, 1971.
[Note: Theses are not included in publication count]
25
B.J Morris – PUBLICATIONS
PATENTS
AWARDED
A Method of Detection of Carcinogenic Papillomavirus
(claims use of polymerase chain reaction technique for detection of the viral types
that cause cervical cancer)
Applicant: The University of Sydney
Inventors: Morris BJ, Nightingale BN
Priority date: 26 Feb 1987
Patents Granted:
Australian Patent No. 611135
European Patent No 88902077.2-2107
British Patent 0357611
German Patent P 3853678.1
Swiss Patent 3853678.1
Swedish Patent 0357611
US Patent No 5,783,412 (granted Jul 21, 1998); after expansion of claims (2002)
Others, that did not proceed past the PPA stage:
Genetic marker for hypertension survival potential
Applicant: The University of Sydney
Inventor: Morris BJ
Priority date: 12 Jun 1998 (PP4095)
International Patent Application filed under PCT on 15 Jun 1999
Essential hypertension TNFR2 gene marker
Applicant: The University of Sydney
Inventor: Morris BJ, Glenn CL, Wang WYS
Priority date: 25 Nov 1998
Genetic marker for overweight phenotype
Applicant: The University of Sydney
Inventor: Morris BJ, Wang WYS, Lin RCY
Priority date: Apr 1999
Polymorphisms in a microsatellite region of a glucocorticoid receptor gene
Applicant: Gemini International Holdings Limited
Inventors: Griffiths LR, Rutherford S, Morris BJ
US Patent Application no. 08/928,293 submitted in 1997
Canadian Patent Application submitted in 1997
26
B.J Morris – PUBLICATIONS
CITATION OF PUBLICATIONS
Statistics were compiled according to the records of all relevant issues of the
Institute for Scientific Information SCI® Annual Science Citation Index and then in
recent years Web of Knowledge on-line database.
Total number of citations of published work according to ISI citation index
of 26 May 2011 = 5,663
The 20 most highly cited research papers and 2 reviews
Pub # (no. of times cited):
16 (438), 80 (269), 110 (224), 1 (166), 181 (150), 63 (130), 10 (123), 134
(122), 175 (122), 127 (107), 166 (102), 9 (91), 68 (84), 82 (81), 90 (74), 46
(68), 15 (67), 188 (65), 183 (66), 8 (60), 71 (57), 57 (57), 102 (53).
27